by Jordana Choucair | Sep 23, 2022 | Opioid/Substance Use Disorders
The FDA released final guidance loosening requirements for distributing naloxone, an opioid overdose medication. The agency said that it will not enforce certain Drug Supply Chain Security Act requirements for public health programs that distribute naloxone to...
by Jordana Choucair | Sep 21, 2022 | Opioid/Substance Use Disorders
West Virginia Attorney General Patrick Morrisey announced that the state reached a $147 million settlement with CVS and Walmart about the pharmacies alleged roles in the opioid epidemic. The state alleged the pharmacies failed to maintain effective controls as a...
by Jordana Choucair | Sep 20, 2022 | Opioid/Substance Use Disorders
The Duke-Margolis Center for Health Policy released a new brief exploring challenges and opportunities for integrating Substance Use Disorder (SUD) treatment into Community Health Centers (CHCs). Drawing on the experiences of CHC leadership and national experts –...
by Jordana Choucair | Sep 20, 2022 | Opioid/Substance Use Disorders
Pew Charitable Trust released a new issue briefing discussing how federal and state regulations are hindering access to opioid use disorder (OUD) treatment. Pew found that nearly all states have rules governing OUD treatments that are not based in evidence and, in...
by Jordana Choucair | Sep 1, 2022 | Opioid/Substance Use Disorders
A new study published in JAMA Psychiatry found that the expanded use of telehealth services during the COVID-19 pandemic was associated with a reduced risk of opioid overdoses. Federal researchers compared two cohorts of Medicare beneficiaries before and during the...
by Jordana Choucair | Aug 31, 2022 | Opioid/Substance Use Disorders
The Duke-Margolis Center for Health Policy announced it is partnering with Third Horizon Strategies (THS) to help communities invest opioid settlement funds. Through a $365,000 grant from the Elevance Health Foundation, the two organizations will create a series of...
Recent Comments